Trials / Active Not Recruiting
Active Not RecruitingNCT07071532
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants
A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of ABBV-932 in Healthy Adult Subjects
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the adverse events and how oral ABBV-932 moves through the body when given with oral Itraconazole in healthy Adults participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABBV-932 | Oral Capsule |
| DRUG | Itraconazole | Oral Capsule |
Timeline
- Start date
- 2025-07-15
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
- First posted
- 2025-07-17
- Last updated
- 2025-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07071532. Inclusion in this directory is not an endorsement.